GPR39 Zn2+-sensing receptor: A new target in antidepressant development?

Journal of Affective Disorders

Volumn 174, Issue , 2015, Pages 89-100

  Młyniec, Katarzyna ^a   Singewald, Nicolas ^b   Holst, Birgitte ^c   Nowak, Gabriel ^a,d  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; BDNF; Depression; GPR39; NMDA; Zinc

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DESIPRAMINE; FLUOXETINE; GPR39 ZINC; IMIPRAMINE; MAGNESIUM CHLORIDE; NEUROPROTECTIVE AGENT; PAROXETINE; REBOXETINE; RECEPTOR; THIAMINE; UNCLASSIFIED DRUG; ZINC; ZINC CHLORIDE; ZINC HISTIDINE DEHYDRATE; ZINC HYDROASPARTATE; ZINC SULFATE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; GPR39 PROTEIN, HUMAN;

ANTIDEPRESSANT ACTIVITY; BODY WEIGHT DISORDER; BRAIN; CHRONIC DRUG ADMINISTRATION; DEPRESSION; GENETIC TRANSCRIPTION; HUMAN; LEARNING; MEMORY; MOOD DISORDER; NEUROPROTECTION; NONHUMAN; REVIEW; SYNAPSE; UPREGULATION; ANIMAL; DEFICIENCY; DEPRESSIVE DISORDER; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES; PSYCHOLOGY; SIGNAL TRANSDUCTION; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DEPRESSIVE DISORDER; GLUTAMIC ACID; HUMANS; LEARNING; MEMORY; MOLECULAR TARGETED THERAPY; MOOD DISORDERS; NEUROPROTECTIVE AGENTS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; UP-REGULATION; WEIGHT GAIN; WEIGHT LOSS; ZINC;

EID: 84918579143     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.11.033     Document Type: Review

References (150)

1. L. Akinfiresoye, and Y. Tizabi Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR Psychopharmacology 230 2013 291 298 10.1007/s00213-013-3153-2
2. American Psychiatric Association The APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry Am. J. Psychiatry 144 1987 1253 1262
3. D. Amital, L. Fostick, A. Silberman, R. Calati, C. Spindelegger, A. Serretti, A. Juven-Wetzler, D. Souery, J. Mendlewicz, S. Montgomery, S. Kasper, and J. Zohar Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder Eur. Neuropsychopharmacol. 23 2013 895 901 10.1016/j.euroneuro.2012.09.002
4. F. Artigas Developments in the field of antidepressants, where do we go now? Eur Neuropsychopharmacol 2013 10.1016/j.euroneuro.2013.04.013
5. + exchange in colonocytes mediated by the zinc-sensing receptor J. Biol. Chem. 279 2004 51804 51816 10.1074/jbc.M406581200
6. A.K. Baltaci, and R. Mogulkoc Leptin and zinc relation: in regulation of food intake and immunity Indian J. Endocrinol. Metab. 16 2012 S611 S616 10.4103/2230-8210.105579
7. T.G. Banke, and G. Gegelashvili Tonic activation of group I mGluRs modulates inhibitory synaptic strength by regulating KCC2 activity J. Physiol. 586 2008 4925 4934 10.1113/jphysiol.2008.157024
8. L. Besser, E. Chorin, I. Sekler, W.F. Silverman, S. Atkin, J.T. Russell, and M. Hershfinkel Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus J. Neurosci. 29 2009 2890 2901 10.1523/JNEUROSCI.5093-08.2009
9. Boehm, M., Hepworth, D., Loria, P.M., Norquay, L.D., Filipski, K.J., Chin, J.E., Cameron, K.O., Brenner, M., Bonnette, P., Cabral, S., Conn, E., Ebner, D.C., Gautreau, D., Hadcock, J., Lee, E.C.Y., Mathiowetz, A.M., Morin, M., Rogers, L., Smith, A., Vanvolkenburg, M., Carpino, P.A., 2013. Chemical probe identification platform for orphan GPCRs using focused compound screening: GPR39 as a case example, pp. 13-18.
10. E. Chorin, O. Vinograd, I. Fleidervish, D. Gilad, S. Herrmann, I. Sekler, E. Aizenman, and M. Hershfinkel Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor J. Neurosci. 31 2011 12916 12926 10.1523/JNEUROSCI.2205-11.2011
11. K. Cies̈lik, B. Klenk-Majewska, Z. Danilczuk, A. Wróbel, T. Łupina, and G. Ossowska Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats Pharmacol. Rep. 59 2007 46 52
12. L. Cohen, H. Azriel-Tamir, N. Arotsker, I. Sekler, and M. Hershfinkel Zinc sensing receptor signaling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterin PLoS One 7 2012 e35482 10.1371/journal.pone.0035482
13. T.B. Cole, H.J. Wenzel, K.E. Kafer, P.A. Schwartzkroin, and R.D. Palmiter Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene Proc. Natl. Acad. Sci. USA 96 1999 1716 1721
14. R.S. Corniola, N.M. Tassabehji, J. Hare, G. Sharma, and C.W. Levenson Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms Brain Res. 1237 2008 52 61 10.1016/j.brainres.2008.08.040
15. R.J. Cousins, M.A. Dunn, A.S. Leinart, K.C. Yedinak, and R.A. DiSilvestro Coordinate regulation of zinc metabolism and metallothionein gene expression in rats Am. J. Physiol. 251 1986 E688 E694
16. L. Cui, Y. Takagi, M. Wasa, Y. Iiboshi, J. Khan, R. Nezu, and A. Okada Induction of nitric oxide synthase in rat intestine by interleukin-1alpha may explain diarrhea associated with zinc deficiency J. Nutr. 127 1997 1729 1736
17. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1913 1920 10.1016/j.pnpbp.2008.09.006
18. D. Daaboul, E. Rosenkranz, P. Uciechowski, and L. Rink Repletion of zinc in zinc-deficient cells strongly up-regulates IL-1β-induced IL-2 production in T-cells Metallomics 4 2012 1088 1097 10.1039/c2mt20118f
19. I. Depoortere GI functions of GPR39: novel biology Curr. Opin. Pharmacol. 12 2012 647 652 10.1016/j.coph.2012.07.019
20. S. Dittmer, M. Sahin, A. Pantlen, A. Saxena, D. Toutzaris, A.-L. Pina, A. Geerts, S. Golz, and A. Methner The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor J. Biol. Chem. 283 2008 7074 7081 10.1074/jbc.M704323200
21. U. Doboszewska, M. Sowa-Kućma, K. Młyniec, B. Pochwat, M. Hołuj, B. Ostachowicz, A. Pilc, G. Nowak, and B. Szewczyk Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor Prog. Neuropsychopharmacol. Biol. Psychiatry 56 2015 254 263 10.1016/j.pnpbp.2014.09.013
22. R.S. Duman, G.R. Heninger, and E.J. Nestler A molecular and cellular theory of depression Arch. Gen. Psychiatry 54 1997 597 606
23. Y. Dwivedi, J.S. Rao, H.S. Rizavi, J. Kotowski, R.R. Conley, R.C. Roberts, C.A. Tamminga, and G.N. Pandey Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects Arch. Gen. Psychiatry 60 2003 273 282
24. K.L. Egerod, B. Holst, P.S. Petersen, J.B. Hansen, J. Mulder, T. Hökfelt, and T.W. Schwartz GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue Mol. Endocrinol. 21 2007 1685 1698 10.1210/me.2007-0055
25. K.L. Egerod, C. Jin, P.S. Petersen, N. Wierup, F. Sundler, B. Holst, and T.W. Schwartz β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-induced hyperglycemia Int. J. Endocrinol. 2011 2011 401258 10.1155/2011/401258
26. D.J. Eide The oxidative stress of zinc deficiency Metallomics 3 2011 1124 1129 10.1039/c1mt00064k
27. M. Fava, and K.G. Davidson Definition and epidemiology of treatment-resistant depression Psychiatr. Clin. North Am. 19 1996 179 200
28. R. Foresti, S.K. Bains, T.S. Pitchumony, L.E. de Castro Brás, F. Drago, J.-L. Dubois-Randé, C. Bucolo, and R. Motterlini Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells Pharmacol. Res. 76 2013 132 148 10.1016/j.phrs.2013.07.010
29. C.J. Frederickson, M.A. Klitenick, W.I. Manton, and J.B. Kirkpatrick Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat Brain Res. 273 1983 335 339
30. C.J. Frederickson, J.-Y. Koh, and A.I. Bush The neurobiology of zinc in health and disease Nat. Rev. Neurosci. 6 2005 449 462 10.1038/nrn1671
31. C.J. Frederickson, and D.W. Moncrieff Zinc-containing neurons Biol. Signals 3 1994 127 139
32. H.-L. Gao, H. Xu, N. Xin, W. Zheng, Z.-H. Chi, and Z.-Y. Wang Disruption of the CaMKII/CREB signaling is associated with zinc deficiency-induced learning and memory impairments Neurotox. Res. 19 2011 584 591 10.1007/s12640-010-9206-y
33. H.-L. Gao, W. Zheng, N. Xin, Z.-H. Chi, Z.-Y. Wang, J. Chen, and Z.-Y. Wang Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and -independent signaling pathways Neurotox. Res. 16 2009 416 425 10.1007/s12640-009-9072-7
34. L.S.B. Garcia, C.M. Comim, S.S. Valvassori, G.Z. Réus, L. Stertz, F. Kapczinski, E.C. Gavioli, and J. Quevedo Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 450 455 10.1016/j.pnpbp.2009.01.004
35. C. Gauthier, C. Hassler, L. Mattar, J.-M. Launay, J. Callebert, H. Steiger, J.-C. Melchior, B. Falissard, S. Berthoz, V. Mourier-Soleillant, F. Lang, M. Delorme, X. Pommereau, P. Gerardin, S. Bioulac, M. Bouvard, and N. Godart Symptoms of depression and anxiety in anorexia nervosa: links with plasma tryptophan and serotonin metabolism Psychoneuroendocrinology 39 2014 170 178 10.1016/j.psyneuen.2013.09.009
36. D. Guidolin, P. Polato, G. Venturin, A. Zanotti, E. Mocchegiani, N. Fabris, and M.G. Nunzi Correlation between zinc level in hippocampal mossy fibers and spatial memory in aged rats Ann. N. Y. Acad. Sci. 673 1992 187 193
37. 2+/calmodulin-dependent protein kinases II and IV both promote survival but differ in their effects on axon growth in spiral ganglion neurons J. Neurosci. Res. 72 2003 169 184 10.1002/jnr.10551
38. C. Haw, and J. Stubbs Patient information leaflets for antidepressants: are patients getting the information they need? J. Affect. Disord. 128 2011 165 170 10.1016/j.jad.2010.06.034
39. U. Heresco-Levy, and D.C. Javitt The role of N-methyl-d-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes Eur. Neuropsychopharmacol. 8 1998 141 152
40. 2+ and regulates ion transport Proc. Natl. Acad. Sci. USA 98 2001 11749 11754 10.1073/pnas.201193398
41. M. Hershfinkel, W. Silverman, and I. Sekler The zinc sensing receptor, a link between zinc and cell signaling Mol. Med. 3 2007 1 6 10.2119/2006
42. N. Ho, M.S. Sommers, and I. Lucki Effects of diabetes on hippocampal neurogenesis: links to cognition and depression Neurosci. Biobehav. Rev. 37 2013 1346 1362 10.1016/j.neubiorev.2013.03.010
43. B. Holst, K.L. Egerod, C. Jin, P.S. Petersen, M.V. Hald, A.M.E. Sprinkel, J. Størling, T. Mandrup-Poulsen, J.J. Holst, P. Thams, C. Orskov, N. Wierup, F. Sundler, O.D. Madsen, and T.W. Schwartz G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction Endocrinology 150 2009 2577 2585 10.1210/en.2008-1250
44. B. Holst, K.L. Egerod, E. Schild, S.P. Vickers, S. Cheetham, L.-O. Gerlach, L. Storjohann, C.E. Stidsen, R. Jones, A.G. Beck-Sickinger, and T.W. Schwartz GPR39 signaling is stimulated by zinc ions but not by obestatin Endocrinology 148 2007 13 20 10.1210/en.2006-0933
45. B. Holst, N.D. Holliday, A. Bach, C.E. Elling, H.M. Cox, and T.W. Schwartz Common structural basis for constitutive activity of the ghrelin receptor family J. Biol. Chem. 279 2004 53806 53817 10.1074/jbc.M407676200
46. C. Hotz, and K.H. Brown Identifying populations at risk of zinc deficiency: the use of supplementation trials Nutr. Rev. 59 2001 80 84
47. L. Ibrahim, N. Diazgranados, D.A. Luckenbaugh, R. Machado-Vieira, J. Baumann, A.G. Mallinger, and C.A. Zarate Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 1155 1159 10.1016/j.pnpbp.2011.03.019
48. Institute of Medicine, Food and Nutrition Board Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001 2001 National Academy Press Washington, D.C. 1 s8
49. D.V. Iosifescu The relation between mood, cognition and psychosocial functioning in psychiatric disorders Eur. Neuropsychopharmacol. 22 Suppl 3 2012 S499 S504 10.1016/j.euroneuro.2012.08.002
50. Y. Ishitobi, J. Akiyoshi, S. Honda, T. Ninomiya, M. Kanehisa, Y. Tanaka, J. Tsuru, K. Isogawa, H. Kitamura, and Y. Fujikura Administration of antisense DNA for GPR39-1b causes anxiolytic-like responses and appetite loss in rats Neurosci. Res. 72 2012 257 262 10.1016/j.neures.2011.12.002
51. V.R. Jackson, H.-P. Nothacker, and O. Civelli GPR39 receptor expression in the mouse brain Neuroreport 17 2006 813 816 10.1097/01.wnr.0000215779.76602.93
52. J.P.R. Jacobsen, and A. Mørk Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat Brain Res. 1110 2006 221 225 10.1016/j.brainres.2006.06.077
53. N. Katalinic, R. Lai, A. Somogyi, P.B. Mitchell, P. Glue, and C.K. Loo Ketamine as a new treatment for depression: a review of its efficacy and adverse effects Aust. N. Z. J. Psychiatry 47 2013 710 727 10.1177/0004867413486842
54. 2+-induced cell death Neuroreport 14 2003 187 190 10.1097/01.wnr.0000054273.81804.31
55. S. Kloiber, M. Ising, S. Reppermund, S. Horstmann, T. Dose, M. Majer, J. Zihl, H. Pfister, P.G. Unschuld, F. Holsboer, and S. Lucae Overweight and obesity affect treatment response in major depression Biol. Psychiatry 62 2007 321 326 10.1016/j.biopsych.2006.10.001
56. B. Kroczka, P. Branski, A. Palucha, A. Pilc, and G. Nowak Antidepressant-like properties of zinc in rodent forced swim test Brain Res. Bull. 55 2001 297 300
57. B. Kroczka, A. Zieba, D. Dudek, A. Pilc, and G. Nowak Zinc exhibits an antidepressant-like effect in the forced swimming test in mice Pol. J. Pharmacol. 52 2000 403 406
58. E. Lauwers, B. Landuyt, L. Arckens, L. Schoofs, and W. Luyten Obestatin does not activate orphan G protein-coupled receptor GPR39 Biochem. Biophys. Res. Commun. 351 2006 21 25
59. S.M. Lehto, T. Tolmunen, A. Ruusunen, S. Voutilainen, T.-P. Tuomainen, and J. Kauhanen Serum zinc and the risk of depression in men: observations from a 20-Year follow-up study Biol. Psychiatry 2014 10.1016/j.biopsych.2014.05.025
60. B. Leonard, and M. Maes Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neurosci. Biobehav. Rev. 36 2012 764 785 10.1016/j.neubiorev.2011.12.005
61. C.W. Levenson, and D. Morris Zinc and neurogenesis: making new neurons from development to adulthood Adv. Nutr. 1 2 2011 96 100 10.3945/an.110.000174.96
62. 2+ J. Neurosci. 21 2001 8015 8025
63. D.D. Lin, A.S. Cohen, and D.A. Coulter Zinc-induced augmentation of excitatory synaptic currents and glutamate receptor responses in hippocampal CA3 neurons J. Neurophysiol. 85 2001 1185 1196
64. Y.M. Lu, F.A. Taverna, R. Tu, C.A. Ackerley, Y.T. Wang, and J. Roder Endogenous Zn(2+) is required for the induction of long-term potentiation at rat hippocampal mossy fiber-CA3 synapses Synapse 38 2000 187 197 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R
65. F.K. Ludka, A.D.E. Zomkowski, M.P. Cunha, T. Dal-Cim, A.L.B. Zeni, A.L.S. Rodrigues, and C.I. Tasca Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels Eur. Neuropsychopharmacol. 23 2013 400 412 10.1016/j.euroneuro.2012.05.005
66. F.S. Luppino, L.M. de Wit, P.F. Bouvy, T. Stijnen, P. Cuijpers, B.W.J.H. Penninx, and F.G. Zitman Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies Arch. Gen. Psychiatry 67 2010 220 229 10.1001/archgenpsychiatry.2010.2
67. M. Maes, P.C. D'Haese, S. Scharpé, P. D'Hondt, P. Cosyns, and M.E. De Broe Hypozincemia in depression J. Affect. Disord. 31 1994 135 140
68. M. Maes, H.Y. Meltzer, E. Bosmans, R. Bergmans, E. Vandoolaeghe, R. Ranjan, and R. Desnyder Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression J. Affect. Disord. 34 1995 301 309
69. M. Maes, I. Mihaylova, and M. De Ruyter Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS J. Affect. Disord. 90 2006 141 147 10.1016/j.jad.2005.11.002
70. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H.Y. Meltzer, C. Altamura, and R. Desnyder Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol. Psychiatry 42 1997 349 358 10.1016/S0006-3223(96)00365-4
71. M.L. Mayer, L. Vyklicky, and G.L. Westbrook Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones J. Physiol. 415 1989 329 350
72. K.K. McKee, C.P. Tan, O.C. Palyha, J. Liu, S.D. Feighner, D.L. Hreniuk, R.G. Smith, A.D. Howard, and L.H. Van der Ploeg Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors Genomics 46 1997 426 434 10.1006/geno.1997.5069
73. I.J. McLoughlin, and J.S. Hodge Zinc in depressive disorder Acta Psychiatr. Scand. 82 1990 451 453
74. K. Młyniec, B. Budziszewska, B. Holst, B. Ostachowicz, and G. Nowak GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus Int. J. Neuropsychopharmacol. 2014 10.1093/ijnp/pyu002 (in press)
75. K. Młyniec, B. Budziszewska, W. Reczyński, U. Doboszewska, A. Pilc, and G. Nowak Zinc deficiency alters responsiveness to antidepressant drugs in mice Pharmacol. Rep. 65 2013 579 592
76. K. Młyniec, B. Budziszewska, W. Reczyński, M. Sowa-Kućma, and G. Nowak The role of the GPR39 receptor in zinc deficient-animal model of depression Behav. Brain Res. 238 2013 30 35 10.1016/j.bbr.2012.10.020
77. K. Młyniec, C.L. Davies, B. Budziszewska, W. Opoka, W. Reczyński, M. Sowa-Kućma, U. Doboszewska, A. Pilc, and G. Nowak Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test Pharmacol. Rep. 64 2012 567 575
78. K. Młyniec, C.L. Davies, I.G. de Agüero Sánchez, K. Pytka, B. Budziszewska, and G. Nowak Essential elements in depression and anxiety Part I. Pharmacol. Rep. 66 2014 534 544 10.1016/j.pharep.2014.03.001
79. K. Młyniec, U. Doboszewska, B. Szewczyk, M. Sowa-Kućma, P. Misztak, W. Piekoszewski, F. Trela, B. Ostachowicz, and G. Nowak The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims Neuropharmacology 79 2014 290 297 10.1016/j.neuropharm.2013.12.001
80. K. Młyniec, and G. Nowak Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants Pharmacol. Rep. 64 2012 249 255
81. K. Młyniec, and G. Nowak GPR39 up-regulation after selective antidepressants Neurochem. Int. 62 2013 936 939 10.1016/j.neuint.2013.02.024
82. D. Moechars, I. Depoortere, B. Moreaux, B. de Smet, I. Goris, L. Hoskens, G. Daneels, S. Kass, L. Ver Donck, T. Peeters, and B. Coulie Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse Gastroenterology 131 2006 1131 1141 10.1053/j.gastro.2006.07.009
83. D.R. Morris, and C.W. Levenson Ion channels and zinc: mechanisms of neurotoxicity and neurodegeneration J. Toxicol. 2012 2012 785647 10.1155/2012/785647
84. A.S. Nakashima, and R.H. Dyck Zinc and cortical plasticity Brain Res. Rev. 59 2009 347 373 10.1016/j.brainresrev.2008.10.003
85. G. Nowak, A. Zięba, D. Dudek, M. Kros̈niak, M. Szymaczek, and M. Schlegel-Zawadzka Serum trace elements in animal models and human depression Part I. Zinc 86 1999 83 86 10.1002/(SICI)1099-1077(199903)14:2<83::AID-HUP74>3.0.CO;2-6
86. S. Nikseresht, S. Etebary, M. Karimian, F. Nabavizadeh, M.R. Zarrindast, and H.R. Sadeghipour Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice Arch. Iran Med. 15 2012 306 311
87. G. Nowak, Y. Li, and I.A. Paul Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment Eur. J. Pharmacol. 295 1996 75 85
88. G. Nowak, G.A. Ordway, and I.A. Paul Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims Brain Res. 675 1995 157 164
89. G. Nowak, and M. Schlegel-Zawadzka Alterations in serum and brain trace element levels after antidepressant treatment: Part I Zinc. Biol. Trace Elem. Res. 67 1999 85 92 10.1007/BF02784278
90. G. Nowak, M. Siwek, D. Dudek, and A. Zięba Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study Pol. J. Pharmacol 55 2003 1143 1147
91. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, A. Pilc, K. Sadlik, and W. Piekoszewski Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats Brain Res. Bull. 61 2003 159 164
92. P. Paoletti, A.M. Vergnano, B. Barbour, and M. Casado Zinc at glutamatergic synapses Neuroscience 158 2009 126 136 10.1016/j.neuroscience.2008.01.061
93. M. Papp, and E. Moryl Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression Eur. J. Pharmacol. 263 1994 1 7
94. A. Partyka, M. Jastrzębska-Więsek, B. Szewczyk, K. Stachowicz, A. Sławińska, E. Poleszak, U. Doboszewska, A. Pilc, and G. Nowak Anxiolytic-like activity of zinc in rodent tests Pharmacol. Rep. 63 2011 1050 1055
95. I.A. Paul, R.T. Layer, P. Skolnick, and G. Nowak Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine Eur. J. Pharmacol. 247 1993 305 311
96. I.A. Paul, G. Nowak, R.T. Layer, P. Popik, and P. Skolnick Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments J. Pharmacol. Exp. Ther. 269 1994 95 102
97. I.A. Paul, and P. Skolnick Glutamate and depression: clinical and preclinical studies Ann. N. Y. Acad. Sci 1003 2003 250 272
98. 2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis J. Neurosci. 33 2013 9259 9272 10.1523/JNEUROSCI.0237-13.2013
99. P.S. Petersen, C. Jin, A.N. Madsen, M. Rasmussen, R. Kuhre, K.L. Egerod, L.B. Nielsen, T.W. Schwartz, and B. Holst Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism FASEB J. 25 2011 3803 3814 10.1096/fj.11-184531
100. F. Pilar-Cuéllar, R. Vidal, A. Díaz, E. Castro, S. Dos Anjos, V. Vargas, B. Romero, and E.M. Valdizán Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity Curr. Pharm. Des. 2013
101. A. Pilc, J.M. Wierońska, and P. Skolnick Glutamate-based antidepressants: preclinical psychopharmacology Biol. Psychiatry 73 2013 1125 1132 10.1016/j.biopsych.2013.01.021
102. P. Popovics, and A.J. Stewart GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions Cell. Mol. Life Sci. 68 2011 85 95 10.1007/s00018-010-0517-1
103. S.H. Preskorn, B. Baker, S. Kolluri, F.S. Menniti, M. Krams, and J.W. Landen An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder J. Clin. Psychopharmacol. 28 2008 631 637 10.1097/JCP.0b013e31818a6cea
104. E. Ranjbar, M.S. Kasaei, M. Mohammad-Shirazi, J. Nasrollahzadeh, B. Rashidkhani, J. Shams, S.-A. Mostafavi, and M.R. Mohammadi Effects of zinc supplementation in patients with major depression: a randomized clinical trial Iran. J. Psychiatry 8 2013 73 79
105. E. Ranjbar, J. Shams, M. Sabetkasaei, M. M-Shirazi, B. Rashidkhani, A. Mostafavi, E. Bornak, and J. Nasrollahzadeh Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression Nutr. Neurosci. 17 2014 65 71 10.1179/1476830513Y.0000000066
106. C.E. Romanoski, N. Che, F. Yin, N. Mai, D. Pouldar, M. Civelek, C. Pan, S. Lee, L. Vakili, W.-P. Yang, P. Kayne, I.N. Mungrue, J.A. Araujo, J.A. Berliner, and A.J. Lusis Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1 Circ. Res. 109 2011 e27 e41 10.1161/CIRCRESAHA.111.241869
107. A.O. Rosa, J. Lin, J.B. Calixto, A.R. Santos, and A.L. Rodrigues Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav. Brain Res. 144 2003 87 93 10.1016/S0166-4328(03)00069-X
108. J.M. Ryu, M.Y. Lee, S.P. Yun, and H.J. Han Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR J. Cell. Physiol. 218 2009 558 567 10.1002/jcp.21628
109. J. Samardzić, K. Savić, N. Stefanović, R. Matunović, D. Baltezarević, M. Obradović, J. Jancić, D. Oprić, and D. Obradović Anxiolytic and antidepressant effect of zinc on rats and its impact on general behavioural parameters Vojnosanit Pregl. 70 2013 391 395
110. I. Sekler, S.L. Sensi, M. Hershfinkel, and W.F. Silverman Mechanism and regulation of cellular zinc transport Mol. Med. 13 2007 337 343 10.2119/2007-00037
111. S. Sen, R. Duman, and G. Sanacora Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications Biol. Psychiatry 64 2008 527 532 10.1016/j.biopsych.2008.05.005
112. S.L. Sensi, P. Paoletti, A.I. Bush, and I. Sekler Zinc in the physiology and pathology of the CNS Nat. Rev. Neurosci. 10 2009 780 791 10.1038/nrn2734
113. S.L. Sensi, P. Paoletti, J.-Y. Koh, E. Aizenman, A.I. Bush, and M. Hershfinkel The neurophysiology and pathology of brain zinc J. Neurosci. 31 2011 16076 16085 10.1523/JNEUROSCI.3454-11.2011
114. R.C. Shelton, J. Claiborne, M. Sidoryk-Wegrzynowicz, R. Reddy, M. Aschner, D.A. Lewis, and K. Mirnics Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression Mol. Psychiatry 16 2011 751 762 10.1038/mp.2010.52
115. M. Siwek, D. Dudek, I.A. Paul, M. Sowa-Kućma, A. Zieba, P. Popik, A. Pilc, and G. Nowak Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study J. Affect. Disord. 118 2009 187 195 10.1016/j.jad.2009.02.014
116. M. Siwek, D. Dudek, M. Schlegel-Zawadzka, A. Morawska, W. Piekoszewski, W. Opoka, A. Zieba, A. Pilc, P. Popik, and G. Nowak Serum zinc level in depressed patients during zinc supplementation of imipramine treatment J. Affect. Disord. 126 2010 447 452 10.1016/j.jad.2010.04.024
117. M. Siwek, B. Szewczyk, D. Dudek, K. Styczeń, M. Sowa-Kućma, K. Młyniec, A. Siwek, L. Witkowski, B. Pochwat, and G. Nowak Zinc as a marker of affective disorders Pharmacol. Rep. 65 2013 1512 1518
118. P. Skolnick Antidepressants for the new millennium Eur. J. Pharmacol. 375 1999 31 40
119. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1996 23 26 10.1055/s-2007-979537
120. Z. Solati, S. Jazayeri, M. Tehrani-Doost, S. Mahmoodianfard, and M.R. Gohari Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial Nutr. Neurosci 2014 10.1179/1476830513Y.0000000105
121. M. Sowa-Kućma, B. Legutko, B. Szewczyk, K. Novak, P. Znojek, E. Poleszak, M. Papp, A. Pilc, and G. Nowak Antidepressant-like activity of zinc: further behavioral and molecular evidence J. Neural Transm. 115 2008 1621 1628 10.1007/s00702-008-0115-7
122. M. Sowa-Kućma, B. Szewczyk, K. Sadlik, W. Piekoszewski, F. Trela, W. Opoka, E. Poleszak, A. Pilc, and G. Nowak Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims J. Affect. Disord. 151 2013 924 931 10.1016/j.jad.2013.08.009
123. 2+ agonism in the extracellular domain of GPR39 FEBS Lett. 582 2008 2583 2588 10.1016/j.febslet.2008.06.030
124. W. Swardfager, N. Herrmann, G. Mazereeuw, K. Goldberger, T. Harimoto, and K.L. Lanctôt Zinc in depression: a meta-analysis Biol. Psychiatry 74 2013 872 878 10.1016/j.biopsych.2013.05.008
125. W. Swardfager, N. Herrmann, G. Mazereeuw, and K.L. Lanctôt Reply to: serum zinc and the risk of depression in men: observations from a 20-year follow-up study Biol. Psychiatry 2014 10.1016/j.biopsych.2014.06.006
126. W. Swardfager, N. Herrmann, R.S. McIntyre, G. Mazereeuw, K. Goldberger, D.S. Cha, Y. Schwartz, and K.L. Lanctôt Potential roles of zinc in the pathophysiology and treatment of major depressive disorder Neurosci. Biobehav. Rev. 37 2013 911 929 10.1016/j.neubiorev.2013.03.018
127. B. Szewczyk, P. Brański, J.M. Wierońska, A. Pałucha, A. Pilc, and G. Nowak Interaction of zinc with antidepressants in the forced swimming test in mice Pol. J. Physiol. 54 2002 681 685
128. B. Szwczyk, E. Poleszak, P. Wlaź, A. Wróbel, E. Blicharska, A. Cichy, M. Dybała, A. Siwek, L. Pomierny-Chamioło, A. Piotrowska, P. Brański, A. Pilc, and G. Nowak The invelvement of serotonergic system in the antidepressant effect of zinc in the forced swim test Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 323 329 10.1016/j.pnpbp.2008.12.011
129. M. Szymańska, B. Budziszewska, L. Jaworska-Feil, A. Basta-Kaim, M. Kubera, M. Les̈kiewicz, M. Regulska, and W. Lasoń The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats Psychoneuroendocrinology 34 2009 822 832 10.1016/j.psyneuen.2008.12.012
130. A. Takeda, A. Minami, Y. Seki, and N. Oku Inhibitory function of zinc against excitation of hippocampal glutamatergic neurons Epilepsy Res. 57 2003 169 174 10.1016/j.eplepsyres.2003.11.003
131. A. Takeda, and H. Tamano Proposed glucocorticoid-mediated zinc signaling in the hippocampus Metallomics 4 2012 614 618 10.1039/c2mt20018j
132. A. Takeda, H. Tamano, F. Kan, H. Itoh, and N. Oku Anxiety-like behavior of young rats after 2-week zinc deprivation Behav. Brain Res. 177 2007 1 6 10.1016/j.bbr.2006.11.023
133. A. Takeda, H. Tamano, T. Ogawa, S. Takada, M. Ando, N. Oku, and M. Watanabe Significance of serum glucocorticoid and chelatable zinc in depression and cognition in zinc deficiency Behav. Brain Res. 226 2012 259 264 10.1016/j.bbr.2011.09.026
134. N.M. Tassabehji, R.S. Corniola, A. Alshingiti, and C.W. Levenson Zinc deficiency induces depression-like symptoms in adult rats Physiol. Behav. 95 2008 365 369 10.1016/j.physbeh.2008.06.017
135. F. Tremblay, M. Perreault, L.D. Klaman, J.F. Tobin, E. Smith, and R.E. Gimeno Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39 Endocrinology 148 2007 501 506 10.1210/en.2006-1275
136. S.E.M. van Dijk, A.D. Pols, M.C. Adriaanse, J.E. Bosmans, P.J.M. Elders, H.W.J. van Marwijk, and M.W. van Tulder Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial BMC Psychiatry 13 2013 128 10.1186/1471-244X-13-128
137. P.J. Verhulst, A. Lintermans, S. Janssen, D. Loeckx, U. Himmelreich, J. Buyse, J. Tack, and I. Depoortere GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity J. Neuroendocrinol. 23 2011 490 500 10.1111/j.1365-2826.2011.02132.x
138. R.A. Wapnir Zinc deficiency, malnutrition and the gastrointestinal tract J. Nutr. 130 2000 1388S 1392SS
139. M. Watanabe, H. Tamano, T. Kikuchi, and A. Takeda Susceptibility to stress in young rats after 2-week zinc deprivation Neurochem. Int. 56 2010 410 416 10.1016/j.neuint.2009.11.014
140. N. Whittle, G. Lubec, and N. Singewald Zinc deficiency induces enhanced depression-like behavior and altered limbic activation reversed by antidepressant treatment in mice Amino Acids 36 2009 147 158 10.1007/s00726-008-0195-6
141. P. Willner, J. Scheel-Krüger, and C. Belzung The neurobiology of depression and antidepressant action Neurosci. Biobehav. Rev. 37 2013 2331 2371 10.1016/j.neubiorev.2012.12.007
142. J. Wójcik, D. Dudek, M. Schlegel-Zawadzka, M. Grabowska, A. Marcinek, E. Florek, W. Piekoszewski, R.J. Nowak, W. Opoka, and G. Nowak Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels Pharmacol. Rep. 58 2006 571 576
143. C. Yang, T. Hong, J. Shen, J. Ding, X.-W. Dai, Z.-Q. Zhou, and J.-J. Yang Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus Exp. Ther. Med 5 2013 1093 1096 10.3892/etm.2013.930
144. Y. Yang, X.-P. Jing, S.-P. Zhang, R.-X. Gu, F.-X. Tang, X.-L. Wang, Y. Xiong, M. Qiu, X.-Y. Sun, D. Ke, J.-Z. Wang, and R. Liu High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling PLoS One 8 2013 e55384 10.1371/journal.pone.0055384
145. 2+ as an endogenous agonist of GPR39 from fetal bovine serum J. Recept. Signal Transduct. Res. 27 2007 235 246 10.1080/10799890701506147
146. S.-I. Yasuda, and J. Ishida GPR39-1b, the 5-transmembrane isoform of GPR39 interacts with neurotensin receptor NTSR1 and modifies its function J. Recept. Signal Transduct. Res. 9893 2014 1 6 10.3109/10799893.2014.885050
147. X. Yu, T. Ren, and X. Yu Disruption of calmodulin-dependent protein kinase II α/brain-derived neurotrophic factor (α-CaMKII/BDNF) signalling is associated with zinc deficiency-induced impairments in cognitive and synaptic plasticity Br. J. Nutr. 110 2013 2194 2200 10.1017/S0007114513001657
148. C.A. Zarate, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh, D.S. Charney, and H.K. Manji A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression Arch. Gen. Psychiatry 63 2006 856 864 10.1001/archpsyc.63.8.856
149. C.K. Zhang, J. Hewett, J. Hemming, T. Grant, H. Zhao, C. Abraham, I. Oikonomou, M. Kanakia, J.H. Cho, and D.D. Proctor The influence of depression on quality of life in patients with inflammatory bowel disease Inflamm. Bowel Dis. 19 2013 1732 1739 10.1097/MIB.0b013e318281f395
150. J. V Zhang, P.-G. Ren, O. Avsian-Kretchmer, C.-W. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake Science 310 2005 996 999 10.1126/science.1117255